SCHEMBL29795348

SCHEMBL29795348

Clc1nc(Cl)c2cc(Cl)c(Cl)nc2n1

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
ALOX15 P16050 1/20 0.30
TSHR P16473 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24755330 1.00 ALDH1A1 (0.30) ALDH1A1ALOX15TSHR
SCHEMBL27147798 0.81 MEN1 (0.31)
SCHEMBL30065127 0.78 KEAP1 (0.37)
SCHEMBL24672358 0.78 KEAP1 (0.37)
SCHEMBL29924915 0.78 KEAP1 (0.37)
SCHEMBL25988924 0.77
SCHEMBL24009531 0.72 CYP1A2 (0.42) ALDH1A1
SCHEMBL30160371 0.72 CYP1A2 (0.42) ALDH1A1
SCHEMBL24342281 0.71 TDP1 (0.37)
SCHEMBL29795360 0.71 PDE4A (0.38) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022262686-A1 KRAS G12D INHIBITORS JINGRUI BIOPHARMA CO., LTD. (CN) 2022-12-22 WO disclosed
WO-2022171191-A1 COMPOUNDS AS ANTICANCER AGENTS JINGRUI BIOPHARMA CO., LTD. (CN) 2022-08-18 WO disclosed